A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

NCT02132637 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin Peglispro
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company